Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Ovarian Neoplasms 2Uveal Melanoma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Hyperthermia 1Fallopian Tube Neoplasms 1Eye Neoplasms 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1

Interventions

montanide ISA 51 1binimetinib 1belinostat 1Proton Therapy 1Peptides 1Melphalan 1MART-1 Antigen 1MAGEA3 protein, human 1Leuprolide 1Lasers 1Laparotomy 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Eye Neoplasms × Laparotomy × Clear all
NCT00062933 2012-08-20

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
40 enrolled
Dermatologic

Hyperthermia, Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡